BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 10766682)

  • 1. The effect of coenzyme Q10 in patients with congestive heart failure.
    Khatta M; Alexander BS; Krichten CM; Fisher ML; Freudenberger R; Robinson SW; Gottlieb SS
    Ann Intern Med; 2000 Apr; 132(8):636-40. PubMed ID: 10766682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials.
    Lei L; Liu Y
    BMC Cardiovasc Disord; 2017 Jul; 17(1):196. PubMed ID: 28738783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive evaluation of cardiac hemodynamics during exercise in patients with chronic heart failure: effects of short-term coenzyme Q10 treatment.
    Morisco C; Nappi A; Argenziano L; Sarno D; Fonatana D; Imbriaco M; Nicolai E; Romano M; Rosiello G; Cuocolo A
    Mol Aspects Med; 1994; 15 Suppl():s155-63. PubMed ID: 7752827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group.
    Hofman-Bang C; Rehnqvist N; Swedberg K; Wiklund I; Aström H
    J Card Fail; 1995 Mar; 1(2):101-7. PubMed ID: 9420639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coenzyme Q10 treatment in serious heart failure.
    Munkholm H; Hansen HH; Rasmussen K
    Biofactors; 1999; 9(2-4):285-9. PubMed ID: 10416042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study.
    Morisco C; Trimarco B; Condorelli M
    Clin Investig; 1993; 71(8 Suppl):S134-6. PubMed ID: 8241697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical and hemodynamic effects of coenzyme Q10 in congestive cardiomyopathy.
    Sacher HL; Sacher ML; Landau SW; Kersten R; Dooley F; Sacher A; Sacher M; Dietrick K; Ichkhan K
    Am J Ther; 1997; 4(2-3):66-72. PubMed ID: 10423594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coenzyme Q10 as an adjunctive therapy in patients with congestive heart failure.
    Mortensen SA
    J Am Coll Cardiol; 2000 Jul; 36(1):304-5. PubMed ID: 10898453
    [No Abstract]   [Full Text] [Related]  

  • 9. Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study.
    Berman M; Erman A; Ben-Gal T; Dvir D; Georghiou GP; Stamler A; Vered Y; Vidne BA; Aravot D
    Clin Cardiol; 2004 May; 27(5):295-9. PubMed ID: 15188947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coenzyme Q10 terclatrate and creatine in chronic heart failure: a randomized, placebo-controlled, double-blind study.
    Fumagalli S; Fattirolli F; Guarducci L; Cellai T; Baldasseroni S; Tarantini F; Di Bari M; Masotti G; Marchionni N
    Clin Cardiol; 2011 Apr; 34(4):211-7. PubMed ID: 21462215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coenzyme Q10 (ubiquinone) in the treatment of heart failure. Are any positive effects documented?].
    Spigset O
    Tidsskr Nor Laegeforen; 1994 Mar; 114(8):939-42. PubMed ID: 8191473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of coenzyme Q10 in heart failure.
    Weant KA; Smith KM
    Ann Pharmacother; 2005 Sep; 39(9):1522-6. PubMed ID: 16046484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentration of lipoprotein(a) decreases on treatment with hydrosoluble coenzyme Q10 in patients with coronary artery disease: discovery of a new role.
    Singh RB; Niaz MA
    Int J Cardiol; 1999 Jan; 68(1):23-9. PubMed ID: 10077397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure.
    Rosenfeldt F; Hilton D; Pepe S; Krum H
    Biofactors; 2003; 18(1-4):91-100. PubMed ID: 14695924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of taurine in chronic congestive heart failure and its prospective application.
    Azuma J; Sawamura A; Awata N
    Jpn Circ J; 1992 Jan; 56(1):95-9. PubMed ID: 1538580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction.
    Singh RB; Wander GS; Rastogi A; Shukla PK; Mittal A; Sharma JP; Mehrotra SK; Kapoor R; Chopra RK
    Cardiovasc Drugs Ther; 1998 Sep; 12(4):347-53. PubMed ID: 9825179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of coenzyme Q10 in chronic heart failure, angina, and hypertension.
    Tran MT; Mitchell TM; Kennedy DT; Giles JT
    Pharmacotherapy; 2001 Jul; 21(7):797-806. PubMed ID: 11444576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP;
    JACC Heart Fail; 2014 Dec; 2(6):641-9. PubMed ID: 25282031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction.
    Lepore JJ; Olson E; Demopoulos L; Haws T; Fang Z; Barbour AM; Fossler M; Davila-Roman VG; Russell SD; Gropler RJ
    JACC Heart Fail; 2016 Jul; 4(7):559-566. PubMed ID: 27039125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.